Download presentation
Presentation is loading. Please wait.
Published byStijn de Wit Modified over 6 years ago
1
Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis
Eveline van der Veer, PhD, Suzanne Arends, PhD, Sjoukje van der Hoek, BSc, Joris B. Versluijs, BSc, Jan G.R. de Monchy, MD, PhD, Joanna N.G. Oude Elberink, MD, PhD, Jasper J. van Doormaal, MD, PhD Journal of Allergy and Clinical Immunology Volume 134, Issue 6, Pages (December 2014) DOI: /j.jaci Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Fig 1 Flowchart of handling of fracture data from patients with ISM.
Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig 2 Lifetime FFxs in patients before and/or after the diagnosis of ISM. A, All patients with ISM (n = 221). B, Patients with ISM used for the predictor analysis (n = 181). Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
4
Fig 3 FFx-free survival curves of the 5 independent predictors: male sex, sCTX Z-score of +1.0 or greater, hip BMD T-score of −1.0 or less, absence of UP, and use of alcohol. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
5
Fig 4 FFx-free survival curves per MastFx score (0-5) using a prediction model consisting of 5 patient characteristics. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.